$placeNoAds is not true
placeAds(In the statement, class 5 has been corrected per the Restriction dated 3/10/22 and per the Fnote dated 3/21/22.;Pharmaceutical preparations [ and substances ] for the* prevention and * treatment of [ damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory [, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders; vaccines;, 'body') is not true
UZOYA Brand - FindOwnerSearch

UZOYA

Welcome to the Brand page for “UZOYA”, which is offered here for In the statement, class 5 has been corrected per the restriction dated 3/10/22 and per the fnote dated 3/21/22.;pharmaceutical preparations [ and substances ] for the* prevention and * treatment of [ damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory [, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders; vaccines;.

Its status is currently believed to be active. Its class is unavailable. “UZOYA” is believed to be currently owned by “GLAXO GROUP LIMITED”.


Owner:
GLAXO GROUP LIMITED
Owner Details
Description:
In the statement, class 5 has been corrected per the Restriction dated 3/10/22 and per the Fnote dated 3/21/22.;Pharmaceutical preparations [ and substances ] for the* prevention and * treatment of [ damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, ] oncological, [ hepatological, ophthalmic, ] respiratory [, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ] diseases and disorders; vaccines;
Categories: STATEMENT